Osteoimmunology in skeletal cell biology and disease.
Osteoimmunology in skeletal cell biology and disease.
复制标题
骨骼细胞生物学和疾病中的骨免疫学。
DOI:
10.1080/08916930701694808
复制
发表时间:
2008
期刊:
影响因子:
3.5
通讯作者:
McHugh,KevinP
中科院分区:
文献类型:
--
作者:
McHugh,KevinP
Scientific advances within the last decade have revolutionized the field of skeletal biology. Genetic and genomic approaches to skeletal cell biology led the revolution with the identification of some unexpected cellular and cytokine interactions. The prevalence of immune cells and mediators as major regulatory factors in skeletal biology has been one such revelation. The term “Osteoimmunology” was first suggested by Arron and Choi to describe this new discipline of Biology which seeks to define the roles and interactions of immune cells with skeletal cells and to identify shared pathways and signaling molecules. Here we present reviews on osteoimmunological cellular interactions, considering shared intracellular signaling molecules, cell surface molecules, and cytokines between immune and bone cells. These osteoimmunological interactions are discussed in light of metabolic bone turnover, in inflammation and in disease. We also wish to perhaps broaden the scope of osteoimmunology to be more inclusive of innate immune interactions, resolution of inflammation, and novel mediators of signaling between bone metabolism and the immune system. In the first review, Wu, Humphrey, and Nakamura introduce the bone-resorbing osteoclast as an innate immune cell, which is dependent on the cytokines receptor-activator NFkB (RANKL) and macrophage colony stimulating factor for differentiation and function. Recently, the immunoreceptor tyrosinebased activation motif (ITAM) signaling receptors DAP12 and FcRg have been shown to directly impact osteoclast formation, function, and to modulate bone mass. The requirement for ITAM signaling as a costimulatory factor in osteoclast formation parallels that of co-stimulation by ITAM receptors in other TNF family receptor-mediated immune cell functions in other immune cell types. Studies of human and mouse mutations in ITAM receptor pathways are discussed, revealing micro-environmental and focal influences of ITAM signaling on skeletal biology.Toll-like receptors (TLRs) recognize pathogenassociated molecular patterns (PAMPs) and mediate the innate immune responses to them. Dr Bar-Shavit describes the role of these innate immune receptors in bone cell biology, noting the shared signaling pathways for TLRs with RANK signaling. Studies of PAMP effects and TLR signaling in osteoclast formation have often been contradictory with antiand pro-osteoclastic functions reported. Dr Bar-Shavit clarifies the opposing effects of TLRs on osteoclast differentiation, and highlights the requirement for RANKL priming of osteoclast precursors for pro-osteoclastic TLR signaling. Dr Bar-Shavit also addresses PAMP regulation of bone metabolism by cross-talk between osteoclasts and osteoblasts, and presents a model of modulation of bone resorption by PAMPs through TLRs.